LIN SUE-JEAN bought ARQT
November 24, 2025 · Form 4 insider transaction
LIN SUE-JEAN bought 7,220 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $54.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,220
Price
$7.51
Total value
$54.2K
InsiderLIN SUE-JEAN
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 24, 2025
Filing dateNovember 25, 2025
Shares owned after52,007
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.